Literature DB >> 1756470

Partial trisomy 1q. A nonrandom primary chromosomal abnormality in myelodysplastic syndromes?

C Fonatsch1, D Haase, M Freund, H Bartels, H Tesch.   

Abstract

Cytogenetic and clinical data of 11 patients with de novo myelodysplastic syndromes and partial or total trisomy of the long arm of chromosome 1 are presented. In eight of these patients trisomy 1q was the sole karyotypic change and therefore can be classified as a primary chromosome anomaly. A remarkably young median age of 36.5 years was noticed in this patient group.

Entities:  

Mesh:

Year:  1991        PMID: 1756470     DOI: 10.1016/0165-4608(91)90177-v

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  5 in total

1.  Inhibition of hematopoietic protein tyrosine phosphatase augments and prolongs ERK1/2 and p38 activation.

Authors:  Eduard Sergienko; Jian Xu; Wallace H Liu; Russell Dahl; David A Critton; Ying Su; Brock T Brown; Xochella Chan; Li Yang; Ekaterina V Bobkova; Stefan Vasile; Hongbin Yuan; Justin Rascon; Sharon Colayco; Shyama Sidique; Nicholas D P Cosford; Thomas D Y Chung; Tomas Mustelin; Rebecca Page; Paul J Lombroso; Lutz Tautz
Journal:  ACS Chem Biol       Date:  2011-11-17       Impact factor: 5.100

2.  Inhibition of the Hematopoietic Protein Tyrosine Phosphatase by Phenoxyacetic Acids.

Authors:  Ekaterina V Bobkova; Wallace H Liu; Sharon Colayco; Justin Rascon; Stefan Vasile; Carlton Gasior; David A Critton; Xochella Chan; Russell Dahl; Ying Su; Eduard Sergienko; Thomas D Y Chung; Tomas Mustelin; Rebecca Page; Lutz Tautz
Journal:  ACS Med Chem Lett       Date:  2011-02       Impact factor: 4.345

Review 3.  Protein tyrosine phosphatases: structure, function, and implication in human disease.

Authors:  Lutz Tautz; David A Critton; Stefan Grotegut
Journal:  Methods Mol Biol       Date:  2013

4.  Cytogenetic findings in 179 patients with myelodysplastic syndromes.

Authors:  D Haase; C Fonatsch; M Freund; B Wörmann; H Bodenstein; H Bartels; B Stollmann-Gibbels; E Lengfelder
Journal:  Ann Hematol       Date:  1995-04       Impact factor: 3.673

Review 5.  Rare cytogenetic abnormalities in myelodysplastic syndromes.

Authors:  Ulrike Bacher; Julie Schanz; Friederike Braulke; Detlef Haase
Journal:  Mediterr J Hematol Infect Dis       Date:  2015-05-01       Impact factor: 2.576

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.